drugset / Trial / NCT07569289

Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger

NCT07569289

Phase 2 Not yet recruiting 164 enrolled Bedaya Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation

Timeline

Start
2026-06-01
Primary completion
2027-12-01
Completion
2028-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator HCG Unknown 10000 iu Intramuscular
Subject Triptorelin Other / unclassified 0.2 mg Subcutaneous

Indications